About us

We are passionate about bringing the lab to the patient.

Enzyre’s mission is to save patients from bleeding to death. Our Enzypad technology fulfils that mission anywhere in the world.

Meet the management team

Vision

By bringing the lab to the patient, we can improve the quality of life without increasing healthcare costs.

Mission

Save patients from bleeding to death.

Strategy

Develop a handheld device that can run multiple assays in parallel to identify the cause of a bleed so therapy can be adjusted without delay.

Our approach

Our team of experts is innovating near patient diagnostics with a focus on blood coagulation.


Join us on our journey

Enzyre is now preparing to raise €10M in its Series A investment round. The proceeds will be used to (a) finalize the development of the ENZYPAD en ENZYCARD Hemophilia A, (b) manufacture the portable instrument & disposable, and (c) perform studies to obtain regulatory approval in EU & US. The product will be commercialized worldwide through our pharma partner. Interested candidate investors are encouraged to contact us at investors@enzyre.com.

Get involved